Clinical Trials Logo
  1. Home
  2. Septic Arthritis
  3. NCT05341908

Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients

Septic Arthritis Clinical Trial

Official title:
Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients and Clinical and Laboratory Features of Patients Diagnosed With Septic Arthritis

Clinical Trial Summary

This is a prospective, observational study of patients presenting to the emergency departments at 9 EMERGEncy ID NET sites. The objectives of the proposed study are to: 1. Describe the range and proportion of infectious agents in synovial fluid as detected by standard C&S and investigational PCR testing, i.e., Biofire® Film Array® Bone and Joint Infection (BJI) Panel, 2. Describe the epidemiology of patients receiving diagnostic arthrocentesis and those diagnosed with septic arthritis in the emergency department (ED), 3. Determine the prevalence of septic arthritis in US ED patients presenting with an atraumatic painful swollen joint, and 4. Determine the clinical (history and physical examination) and laboratory characteristics of septic arthritis. Study coordinators screen the ED log for adult patients presenting with joint pain and whose treating physician ordered an arthrocentesis. After confirming eligibility, study coordinators approach the patient to explain the study, and present the written consent form. If the patient agrees to participate and consent, the study coordinator completes an enrollment data collection using patient and treating physician interview to gather responses. After enrollment, the study coordinator will ensure that approximately 0.3-1.0 mL of leftover synovial fluid is saved and stored in a freezer for shipment to a central laboratory (Truman Medical Center hospital laboratory, Kansas City, MO) for testing. Approximately 30 days after enrollment, study coordinators complete an electronic medical record (EMR) review.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05341908
Study type Observational
Source Olive View-UCLA Education & Research Institute
Contact
Status Completed
Phase
Start date September 1, 2021
Completion date December 31, 2023
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06003374 - Extended Hip Ultrasound as Anew Protocol for Septic Hip in Children
Active, not recruiting NCT04563325 - Oral-only Antibiotics for Bone and Joint Infections in Children Phase 4
Completed NCT03846804 - Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections N/A
Completed NCT00503438 - Ankle Joint Replacement Outcomes Study
Recruiting NCT04952220 - Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee
Active, not recruiting NCT02565160 - Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques
Recruiting NCT05971745 - Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound
Completed NCT05593874 - Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections
Recruiting NCT02530229 - Arthrocentesis Study N/A
Not yet recruiting NCT05521880 - Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use Phase 4
Completed NCT03802552 - Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections Phase 1
Not yet recruiting NCT05780697 - Short Term Results of Pediatric Septic Hip Arthritis Management in Assiut University Hospitals N/A
Recruiting NCT03704766 - Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis N/A
Not yet recruiting NCT05886166 - Clinical Utility of Exoskeleton Robot Training in Patients With Septic Arthritis After a Thermal Injury: A Case Report N/A
Recruiting NCT04538053 - BonE and Joint Infections - Simplifying Treatment in Children Trial Phase 4
Recruiting NCT04141787 - Ceftriaxone as Home IV for Staph Infections Phase 4
Completed NCT06241365 - The Predictive Role of C-reactive Protein to Albumin Ratio (CAR) in the Treatment of Septic Arthritis in Young Chlidren
Completed NCT03426761 - Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Phase 4
Completed NCT02018952 - Ultrasonography Assessment of Septic Arthritis on Native Joint N/A
Recruiting NCT04284423 - Study of Synovial Lactate Level as Marker of Septic Arthritis